Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martins I et al. – The molecular basis for class II transactivator and HLA–DR expression in melanoma therefore remains unsolved, but the findings linking together the expression of HLA–DR, of chemokines involved in invasiveness, and of nuclear NFkB p50 strongly support the content that MHC II may be a marker of invasive primary melanoma, and could explain the long–standing association of MHC II expression with overall poor prognosis and unfavorable clinical outcome.

Related Articles

Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09    Relevance Score: 91%

ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09    Relevance Score: 91%

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression
Modern Pathology, 11/11/09    Relevance Score: 90%

Spitzoid melanoma
Clinics in Dermatology, 11/11/09    Relevance Score: 90%

Distinct MHC gene expression patterns during progression of melanoma
Genes, Chromosomes and Cancer, 11/02/09    Relevance Score: 90%

Today in Dermatologic Oncology...keeping you current

Surgical excision of skin cancer: the importance of training
British Journal of Dermatology, 12/11/09

A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck
The Surgeon - Journal of the Royal College of Surgeons at Edinburgh and Ireland, 12/11/09

Importance of clear resection margins in anorectal malignant melanoma
British Journal of Surgery, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address